[go: up one dir, main page]

WO2007016621A3 - Utilisation de cellules stromales derivees de tissu adipeux dans une fusion spinale - Google Patents

Utilisation de cellules stromales derivees de tissu adipeux dans une fusion spinale Download PDF

Info

Publication number
WO2007016621A3
WO2007016621A3 PCT/US2006/030078 US2006030078W WO2007016621A3 WO 2007016621 A3 WO2007016621 A3 WO 2007016621A3 US 2006030078 W US2006030078 W US 2006030078W WO 2007016621 A3 WO2007016621 A3 WO 2007016621A3
Authority
WO
WIPO (PCT)
Prior art keywords
adipose tissue
spinal fusion
derived stromal
stromal cells
plethora
Prior art date
Application number
PCT/US2006/030078
Other languages
English (en)
Other versions
WO2007016621A2 (fr
Inventor
Jeffrey M Gimble
Mandi Lopez
Original Assignee
Univ Louisiana State
Jeffrey M Gimble
Mandi Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisiana State, Jeffrey M Gimble, Mandi Lopez filed Critical Univ Louisiana State
Publication of WO2007016621A2 publication Critical patent/WO2007016621A2/fr
Publication of WO2007016621A3 publication Critical patent/WO2007016621A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/3654—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/3654—Cartilage, e.g. meniscus
    • A61L27/3658—Intervertebral discs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A61L27/3856—Intervertebral discs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442—Intervertebral or spinal discs, e.g. resilient
    • A61F2002/445—Intervertebral disc tissue harvest sites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des méthodes et des compositions destinées au traitement d'un trouble osseux. La cellule stromale dérivée de tissu adipeux, isolée de cette invention ainsi que les produits associés présentent une pléthore d'utilisations, notamment mais non seulement, la recherche, le diagnostic et des applications thérapeutiques, telles que des interventions de fusion spinale.
PCT/US2006/030078 2005-08-01 2006-08-01 Utilisation de cellules stromales derivees de tissu adipeux dans une fusion spinale WO2007016621A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/194,270 2005-08-01
US11/194,270 US20070027543A1 (en) 2005-08-01 2005-08-01 Use of adipose tissue-derived stromal cells in spinal fusion

Publications (2)

Publication Number Publication Date
WO2007016621A2 WO2007016621A2 (fr) 2007-02-08
WO2007016621A3 true WO2007016621A3 (fr) 2009-04-23

Family

ID=37695366

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2006/028886 WO2007016112A2 (fr) 2005-08-01 2006-07-26 Cellules du stroma dérivées de tissu adipeux utilisée pour fusion vertébrale
PCT/US2006/030078 WO2007016621A2 (fr) 2005-08-01 2006-08-01 Utilisation de cellules stromales derivees de tissu adipeux dans une fusion spinale

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2006/028886 WO2007016112A2 (fr) 2005-08-01 2006-07-26 Cellules du stroma dérivées de tissu adipeux utilisée pour fusion vertébrale

Country Status (13)

Country Link
US (3) US20070027543A1 (fr)
EP (1) EP1915109A4 (fr)
JP (2) JP2009507527A (fr)
KR (1) KR20080043809A (fr)
CN (1) CN101500514A (fr)
AU (1) AU2006275918A1 (fr)
BR (1) BRPI0614534A2 (fr)
CA (1) CA2617628A1 (fr)
CR (1) CR9774A (fr)
IL (1) IL189179A0 (fr)
RU (1) RU2008107978A (fr)
TW (1) TW200740998A (fr)
WO (2) WO2007016112A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7648509B2 (en) 2003-03-10 2010-01-19 Ilion Medical Llc Sacroiliac joint immobilization
US20090024174A1 (en) * 2007-07-17 2009-01-22 Stark John G Bone screws and particular applications to sacroiliac joint fusion
US8740912B2 (en) 2008-02-27 2014-06-03 Ilion Medical Llc Tools for performing less invasive orthopedic joint procedures
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
US9421109B2 (en) 2010-01-13 2016-08-23 Jcbd, Llc Systems and methods of fusing a sacroiliac joint
US9333090B2 (en) 2010-01-13 2016-05-10 Jcbd, Llc Systems for and methods of fusing a sacroiliac joint
WO2014015309A1 (fr) 2012-07-20 2014-01-23 Jcbd, Llc Système d'ancrage orthopédique et procédés
CA3002234C (fr) 2010-01-13 2020-07-28 Jcbd, Llc Systeme de fusion de fixation d'articulation sacro-iliaque
US9381045B2 (en) 2010-01-13 2016-07-05 Jcbd, Llc Sacroiliac joint implant and sacroiliac joint instrument for fusing a sacroiliac joint
US8936804B2 (en) 2010-01-15 2015-01-20 Rutgers, The State University Of New Jersey Use of vanadium compounds to accelerate bone healing
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
EP2648718B1 (fr) 2010-12-10 2019-05-08 Rutgers, the State University of New Jersey Dispositifs implantables revêtus de composites d'agent mimétique de l'insuline, et procédés associés
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
EP2720628B1 (fr) 2011-06-17 2021-08-11 Jcbd, Llc Système d'implant d'articulation sacro-iliaque
CA2857487C (fr) * 2011-11-29 2021-09-21 Rutgers, The State University Of New Jersey Agents mimetiques de l'insuline en tant que traitement d'appoint therapeutique pour une regeneration osseuse
AU2013235600B2 (en) * 2012-03-21 2017-12-07 Dana-Farber Cancer Institute, Inc. Isolation and use of human lymphoid organ-derived suppressive stromal cells
US10179014B1 (en) 2012-06-01 2019-01-15 Nuvasive, Inc. Systems and methods for promoting sacroiliac joint fusion
US9724149B2 (en) 2013-03-07 2017-08-08 Warsaw Orhtopedic, Inc. Surgical implant system and method
US10245087B2 (en) 2013-03-15 2019-04-02 Jcbd, Llc Systems and methods for fusing a sacroiliac joint and anchoring an orthopedic appliance
US9700356B2 (en) 2013-07-30 2017-07-11 Jcbd, Llc Systems for and methods of fusing a sacroiliac joint
US9826986B2 (en) 2013-07-30 2017-11-28 Jcbd, Llc Systems for and methods of preparing a sacroiliac joint for fusion
US9717539B2 (en) 2013-07-30 2017-08-01 Jcbd, Llc Implants, systems, and methods for fusing a sacroiliac joint
US9510872B2 (en) 2013-03-15 2016-12-06 Jcbd, Llc Spinal stabilization system
EP3011015B1 (fr) * 2013-06-19 2021-02-24 Spinalcyte, LLC Cellules adipeuses pour des applications de chondrocytes
WO2014202837A1 (fr) * 2013-06-20 2014-12-24 Tampereen Yliopisto Milieu contenant un inhibiteur de la mapk p38 et méthode de différenciation ostéogénique
CN105555326B (zh) * 2013-07-01 2019-05-14 A·P·高伟尔 软组织植入物
WO2015017500A1 (fr) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Matrices dérivées de tissu mou acellulaire et leurs procédés de préparation
US9801546B2 (en) 2014-05-27 2017-10-31 Jcbd, Llc Systems for and methods of diagnosing and treating a sacroiliac joint disorder
CA2986702C (fr) 2015-05-21 2023-04-04 David Wang Fibres osseuses corticales demineralisees modifiees
US9839524B2 (en) * 2015-06-22 2017-12-12 Theodore Malinin Modified, pliable, and compressible cortical bone for spinal fusions and other skeletal transplants
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US10549011B2 (en) 2015-10-26 2020-02-04 Osteolife Biomedical, Llc Bone putty and gel systems and methods
US20170128633A1 (en) 2015-11-10 2017-05-11 Theodore Malinin Bioactive Implants and Methods of Making and Using
US10667923B2 (en) 2016-10-31 2020-06-02 Warsaw Orthopedic, Inc. Sacro-iliac joint implant system and method
US10603055B2 (en) 2017-09-15 2020-03-31 Jcbd, Llc Systems for and methods of preparing and fusing a sacroiliac joint
CN108841785A (zh) * 2018-06-15 2018-11-20 广州赛莱拉干细胞科技股份有限公司 脂肪组织消化液和快速获得基质血管成分细胞的方法
US11344354B2 (en) 2019-09-09 2022-05-31 Warsaw Orthopedic, Inc. Surgical instrument and method
US11564812B2 (en) 2019-09-09 2023-01-31 Warsaw Orthopedic, Inc. Surgical instrument and method
WO2023164455A2 (fr) * 2022-02-23 2023-08-31 Aloe Therapeutics Inc Compositions et méthodes pour moduler le système immunitaire

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
US20020082698A1 (en) * 2000-09-18 2002-06-27 Parenteau Nancy L. Method for treating a patient using a cultured connective tissue construct

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
JP4222726B2 (ja) * 1997-12-02 2009-02-12 ゼン‐バイオ，インコーポレイテッド 骨芽細胞の発生および使用
US6100047A (en) * 1999-04-07 2000-08-08 Zen Bio, Inc. Modulation of the sulfonylurea receptor and calcium in adipocytes for treatment of obesity/diabetes
US6153432A (en) * 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
US20050153442A1 (en) * 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US6429013B1 (en) * 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en) * 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US6727528B1 (en) * 2001-03-22 2004-04-27 T-Ram, Inc. Thyristor-based device including trench dielectric isolation for thyristor-body regions
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
WO2005018549A2 (fr) * 2003-08-12 2005-03-03 The Brigham And Women' S Hospital, Inc. Procedes et compositions pour la regeneration des tissus
EP1778293B1 (fr) 2004-07-01 2015-04-22 Cytori Therapeutics, Inc. Methodes d'utilisation de cellules de regeneration dans le traitement de troubles musculo-squelettiques
NL1026712C2 (nl) * 2004-07-23 2006-01-24 Technologiestichting Stw Bioresorbeerbaar botimplantaat.
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
US6240926B1 (en) * 1996-08-08 2001-06-05 The Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
US20020082698A1 (en) * 2000-09-18 2002-06-27 Parenteau Nancy L. Method for treating a patient using a cultured connective tissue construct

Also Published As

Publication number Publication date
US8313743B2 (en) 2012-11-20
CR9774A (es) 2009-09-09
EP1915109A4 (fr) 2011-05-18
BRPI0614534A2 (pt) 2011-04-05
KR20080043809A (ko) 2008-05-19
WO2007016112A3 (fr) 2009-04-23
CA2617628A1 (fr) 2007-02-08
US20130108595A1 (en) 2013-05-02
WO2007016621A2 (fr) 2007-02-08
AU2006275918A1 (en) 2007-02-08
RU2008107978A (ru) 2009-09-10
TW200740998A (en) 2007-11-01
WO2007016112A2 (fr) 2007-02-08
EP1915109A2 (fr) 2008-04-30
JP2009507527A (ja) 2009-02-26
US20070027543A1 (en) 2007-02-01
CN101500514A (zh) 2009-08-05
JP2013048917A (ja) 2013-03-14
IL189179A0 (en) 2008-06-05
US20110076330A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
WO2007016112A3 (fr) Cellules du stroma dérivées de tissu adipeux utilisée pour fusion vertébrale
WO2006083394A3 (fr) Cellules post-partum derivees de tissu placentaire et leurs procedes de production, de culture et d'utilisation
WO2005001076A3 (fr) Cellules post-partum derivees de tissu placentaire et procedes de production et d'utilisation de ces dernieres
WO2011150133A3 (fr) Protéines d'échafaudage à base de fibronectine ayant une stabilité améliorée
IL250946B (en) Nanobodies against tumor necrosis factor-alpha (tnf-alpha)
WO2012019168A3 (fr) Acides nucléiques modifiés et leurs procédés d'utilisation
WO2012008860A3 (fr) Enzymes nitroréductases bactériennes et procédés associés
WO2010093627A3 (fr) Compositions supports à base du domaine de la fibronectine de type iii, procédés et utilisations
PH12012502272A1 (en) Biological materials related to her3
WO2010034032A3 (fr) Procédés pour préparer des compositions de polypeptide purifié
WO2009012109A3 (fr) Composes contenant de la cyanine utiles dans l'imagerie et le traitement du cancer
WO2009080306A8 (fr) Compositions antipelliculaires contenant des peptides
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
WO2012045082A3 (fr) Synthèse d'acides nucléiques et méthodes d'utilisation associées
WO2006071773A3 (fr) Traitement de maladies osteochondrales utilisant des cellules derivees de post-partum et des produits de ceux-ci
WO2006135915A3 (fr) Methodes et compositions de traitement de maladies osseuses degeneratives
WO2007042289A3 (fr) Nanobodies™ et polypeptides diriges contre l'egfr et l'igf-1r
WO2006093857A3 (fr) Procede de production d'une substance cellulaire facilement disponible derivee du sang peripherique et composition de cette substance
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2007097993A3 (fr) Milieu conditionné par des cellules souches embryonnaires humaines ou autres cellules progénitrices et son utilisation
GB201001602D0 (en) Oligopeptidic compounds and uses therof
WO2006130504A3 (fr) Methodes destinees a l'identification de ligands pour des cellules souches et cellules derivees de celles-ci
WO2011069037A3 (fr) Stabilisation et stockage de compositions pharmaceutiques biologiques
WO2009002982A3 (fr) Fluide biologique de gastéropode, procédé de fabrication et de raffinage, et utilisation
PL2373310T3 (pl) Nowe związki 4-(heterocykloalkilo)benzeno-1,3-diolu jako inhibitory tyrozynazy, sposób ich otrzymywania oraz zastosowanie w medycynie i w kosmetykach

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06789184

Country of ref document: EP

Kind code of ref document: A2